Aptose Biosciences Inc.·4

Jan 23, 7:58 PM ET

PLATZER ERICH 4

4 · Aptose Biosciences Inc. · Filed Jan 23, 2023

Insider Transaction Report

Form 4
Period: 2023-01-19
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2023-01-19+100,000100,000 total
    Exercise: $0.66Exp: 2033-01-19Common Shares (100,000 underlying)
Footnotes (1)
  • [F1]The options were granted on January 18, 2022, and vest as follows: 50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4